123 related articles for article (PubMed ID: 38682838)
1. The interplay of psychosis and non-compliance with fatal outcome in an adult with MSUD.
Falah N; Pendyal S; Sasannejad C; Gibson A; Lee YL; McDonald M; Koeberl D
Am J Med Genet A; 2024 Apr; ():e63637. PubMed ID: 38682838
[TBL] [Abstract][Full Text] [Related]
2. Maple syrup urine disease decompensation misdiagnosed as a psychotic event.
Higashimoto T; Whitehead MT; MacLeod E; Starin D; Regier DS
Mol Genet Metab Rep; 2022 Sep; 32():100886. PubMed ID: 35756860
[TBL] [Abstract][Full Text] [Related]
3. Treatment of COVID-19 in a Patient With Maple Syrup Urine Disease.
Morton KF; Goetz RL; Linscott KB; Van Wagoner NJ
Cureus; 2022 Apr; 14(4):e24368. PubMed ID: 35619835
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.
Amaral AU; Wajner M
Neurochem Int; 2022 Jul; 157():105360. PubMed ID: 35577033
[TBL] [Abstract][Full Text] [Related]
5. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.
Abi-Wardé MT; Roda C; Arnoux JB; Servais A; Habarou F; Brassier A; Pontoizeau C; Barbier V; Bayart M; Leboeuf V; Chadefaux-Vekemans B; Dubois S; Assoun M; Belloche C; Alili JM; Husson MC; Lesage F; Dupic L; Theuil B; Ottolenghi C; de Lonlay P
J Inherit Metab Dis; 2017 Nov; 40(6):783-792. PubMed ID: 28905140
[TBL] [Abstract][Full Text] [Related]
6. Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primates.
Skvorak K; Liu J; Kruse N; Mehmood R; Das S; Jenne S; Chng C; Lao UL; Duan D; Asfaha J; Du F; Teadt L; Sero A; Ching C; Riggins J; Pope L; Yan P; Mashiana H; Ismaili MHA; McCluskie K; Huisman G; Silverman AP
J Inherit Metab Dis; 2023 Nov; 46(6):1089-1103. PubMed ID: 37494004
[TBL] [Abstract][Full Text] [Related]
7. Living related versus deceased donor liver transplantation for maple syrup urine disease.
Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
[TBL] [Abstract][Full Text] [Related]
8. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR
Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513
[TBL] [Abstract][Full Text] [Related]
9. Lipid changes in the metabolome of a single case study with maple syrup urine disease (MSUD) after five days of improved diet adherence of controlled branched-chain amino acids (BCAA).
Douglas TD; Newby LK; Eckstrand J; Wixted D; Singh RH
Mol Genet Metab Rep; 2020 Dec; 25():100651. PubMed ID: 33088714
[TBL] [Abstract][Full Text] [Related]
10. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
[TBL] [Abstract][Full Text] [Related]
11. Typical neuroradiological diagnosis of maple syrup urine disease as a precursor to clinical diagnosis. A case report.
Srinivasan KG; Ramprabananth S; Ushanandhini KP; Srividya S
Neuroradiol J; 2009 Dec; 22(5):564-7. PubMed ID: 24209402
[TBL] [Abstract][Full Text] [Related]
12. Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation.
Wessel AE; Mogensen KM; Rohr F; Erick M; Neilan EG; Chopra S; Levy HL; Gray KJ; Wilkins-Haug L; Berry GT
JPEN J Parenter Enteral Nutr; 2015 Sep; 39(7):875-9. PubMed ID: 24618664
[TBL] [Abstract][Full Text] [Related]
13. Maple syrup urine disease (MSUD)--clinical profile of 47 Filipino patients.
Lee JY; Chiong MA; Estrada SC; Cutiongco-De la Paz EM; Silao CL; Padilla CD
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S281-5. PubMed ID: 18989748
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
Barschak AG; Sitta A; Deon M; Barden AT; Dutra-Filho CS; Wajner M; Vargas CR
Metab Brain Dis; 2008 Mar; 23(1):71-80. PubMed ID: 18026828
[TBL] [Abstract][Full Text] [Related]
15. Clues and challenges in the diagnosis of intermittent maple syrup urine disease.
Pode-Shakked N; Korman SH; Pode-Shakked B; Landau Y; Kneller K; Abraham S; Shaag A; Ulanovsky I; Daas S; Saraf-Levy T; Reznik-Wolf H; Vivante A; Pras E; Almashanu S; Anikster Y
Eur J Med Genet; 2020 Jun; 63(6):103901. PubMed ID: 32151765
[TBL] [Abstract][Full Text] [Related]
16. An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease--screened by tandem mass spectrometry.
Lin JF; Chiu PC; Hsu HY; Lin SM; Chen YY; Hsieh KS
Acta Paediatr Taiwan; 2004; 45(5):287-9. PubMed ID: 15868812
[TBL] [Abstract][Full Text] [Related]
17. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
Strauss KA; Carson VJ; Soltys K; Young ME; Bowser LE; Puffenberger EG; Brigatti KW; Williams KB; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Chopko S; Hailey J; Muelly ER; Shellmer DA; Radcliff Z; Rodrigues A; Loeven K; Heaps AD; Mazariegos GV; Morton DH
Mol Genet Metab; 2020 Mar; 129(3):193-206. PubMed ID: 31980395
[TBL] [Abstract][Full Text] [Related]
18. Plasma amino acid and urine organic acid profiles of Filipino patients with maple syrup urine disease (MSUD) and correlation with their neurologic features.
Chiong MA; Tan MA; Cordero CP; Fodra EG; Manliguis JS; Lopez CP; Dalmacio LM
Mol Genet Metab Rep; 2016 Dec; 9():46-53. PubMed ID: 27761412
[TBL] [Abstract][Full Text] [Related]
19. Quantification of Branched-Chain Amino Acids in Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Piri-Moghadam H; Miller A; Pronger D; Vicente F; Charrow J; Haymond S; Lin DC
Methods Mol Biol; 2022; 2546():65-81. PubMed ID: 36127579
[TBL] [Abstract][Full Text] [Related]
20. Treatment of maple syrup urine disease with high flow hemodialysis in a neonate.
Aygün F; Kıykım E; Aktuğlu-Zeybek Ç; Zubarioğlu T; Cam H
Turk J Pediatr; 2019; 61(1):107-110. PubMed ID: 31559730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
